Pennsylvania's Measles Outbreak Reaches 1,222 Cases and Six Deaths. Here Is the Clinic Checklist.
NBC News reports 225 hospitalizations and a CDC field epidemiologist headed to the state. CDC counts 4,410 US cases this year, nearly double all of 2025, and Pennsylvania still recommends an early MMR dose for infants in outbreak areas.
Pennsylvania has at least 1,222 confirmed measles cases and 225 hospitalizations, NBC News reported on Oct. 15, and six people diagnosed with measles have died since August, according to health officials and county coroners. The Centers for Disease Control and Prevention (CDC) acknowledges two of those deaths on its website and says the others are under review.
The outbreak is centered in Lancaster County but is spreading across the state, according to NBC News. Doctors told the outlet the true number of illnesses is likely much higher.
The federal response
An Epidemic Intelligence Service officer, one of CDC's "disease detectives," was scheduled to arrive later that week, NBC reported, and the agency is releasing nearly $4 million for the response. NBC described it as CDC's first in-person help to the state since an August dispute between Health Secretary Robert F. Kennedy Jr. and Gov. Josh Shapiro, who announced the deaths of two unvaccinated people and accused the administration of spreading vaccine misinformation. Kennedy suggested the deaths may have been "fabricated," according to NBC. A CDC spokesperson told the outlet the agency will keep working closely with Pennsylvania health officials.
The Pennsylvania Department of Health confirmed two measles-associated deaths on Aug. 25, which the governor's office called the state's first in 35 years. The department counts a death as measles-associated if it occurs within 30 days of symptom onset in a person with clinical evidence of measles and a positive laboratory test, and is not due to an unrelated cause.
One national figure frames the stakes: 4,410 confirmed US cases this year, against 2,289 in all of 2025.
National context
CDC's measles page, updated Oct. 16 with counts through Oct. 15, lists 4,410 confirmed US cases in 2026, reported by 47 jurisdictions, and 42 new outbreaks, with 96 percent of cases outbreak-associated. All of 2025 had 2,289 cases. CDC lists two deaths, a figure it says is subject to change.
What clinicians should check
CDC's clinical overview asks clinicians to consider measles in any febrile rash illness, particularly after travel or exposure. Patients should be isolated for 4 days after rash onset under airborne precautions, preferably in an airborne infection isolation room, and all staff entering the room should use respiratory protection such as an N95 regardless of presumptive immunity. Measles is immediately notifiable. At first contact, collect serum for IgM and a throat or nasopharyngeal swab for RT-PCR; urine may also carry virus.
There is no FDA-approved antiviral for measles. Vitamin A may be given to children under supervision and should be given to those with severe disease, such as hospitalized children. Pennsylvania asks providers to report suspected cases immediately to the local health department or the state at 877-724-3258, without waiting for lab confirmation.
The early-dose guidance
A statewide health alert issued June 24 recommends one early MMR dose for infants 6 through 11 months who live in or travel to areas with measles. That dose does not count toward the routine series; those infants still need doses at 12 to 15 months and 4 to 6 years. Children over 1 year with no measles vaccine should get two doses at least 28 days apart, children with one dose should get the second now if 28 days have passed, and adults without evidence of immunity should get two doses.
Why it matters
Families in or traveling to affected counties will ask about timing, and the early infant dose is the question most likely to come up. Check the MMR status of your staff, plan how a febrile rash patient enters your office without sitting in the waiting room, and keep the health department number at the front desk. Federal vaccine advice is also in flux; our piece on what stays in force while the vaccine advisory committee is on hold covers the schedule questions.
Reported, fact-checked and edited by The Script Pad's editorial staff.
This article is for professional education and does not replace clinical judgment. Treatment decisions should be based on the individual patient and current guidelines.
